In a BSE filing the company said that it has been granted "one product patent from Australia and one product patent from Eurasia corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".
Pharmaceutical firm Suven Life Sciences today said it has been granted one patent each by Australia and Eurasia for drug used in the treatment of neurodegenrative diseases.
Neurodegenrative diseases include Alzheimer's disease, Schizophrenia and Parkinson's disease.
In a BSE filing the company said that it has been granted "one product patent from Australia and one product patent from Eurasia corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".
These patents are valid until 2030 and 2029 respectively, the company said in a BSE filing.
Suven Life Sciences CEO Venkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena that are being developed for cognitive disorders with high unmet medial need with huge market potential globally."
With these new patents, Suven has a total of 18 granted patents from Australia and 12 from Eurasia. "These patents are exclusive intellectual property of Suven...products out of these inventions may be out-licensed at various phases of clinical development like at Phase-1 and Phase-2," Suven Life Sciences said.
Suven Life Sci stock price
On August 06, 2014, at 14:14 hrs Suven Life Sciences was quoting at Rs 125.30, up Rs 4.10, or 3.38 percent. The 52-week high of the share was Rs 127.30 and the 52-week low was Rs 23.70.
The company's trailing 12-month (TTM) EPS was at Rs 12.34 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 10.15. The latest book value of the company is Rs 22.64 per share. At current value, the price-to-book value of the company is 5.53.
Anda sedang membaca artikel tentang
Suven granted patents for neurodegenrative drug
Dengan url
https://kesehatanda.blogspot.com/2014/08/suven-granted-patents-for.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Suven granted patents for neurodegenrative drug
namun jangan lupa untuk meletakkan link
Suven granted patents for neurodegenrative drug
sebagai sumbernya
0 komentar:
Posting Komentar